{"name": "PalindromX",
 "permalink": "palindromx",
 "crunchbase_url": "http://www.crunchbase.com/company/palindromx",
 "homepage_url": "http://www.palindromx.co.uk",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "PdX",
 "email_address": "",
 "phone_number": "44-(0)-7785-297-186",
 "description": "",
 "created_at": "Mon Mar 22 11:39:56 UTC 2010",
 "updated_at": "Mon Mar 22 11:49:10 UTC 2010",
 "overview": "\u003Cp\u003EPalindromX Limited (PdX) specialises in developing state-of-the-art in vitro diagnostic (IVD) technologies. It is most active in the fields of super-sensitive, multiplexed immunoassay technology, DNA-based vaccination techniques and bone resorption testing services. PdX has generated an intellectual property portfolio in the first two areas that is expected to proceed to grant, providing a potentially lucrative future royalty stream.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       27],
      "assets/images/resized/0008/1222/81222v1-max-150x150.jpg"],
     [[250,
       45],
      "assets/images/resized/0008/1222/81222v1-max-250x250.jpg"],
     [[450,
       81],
      "assets/images/resized/0008/1222/81222v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a3100k",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.growthbusiness.co.uk/news/fundraising-deals/255403/new-funding-for-blood-testing-company.thtml",
    "source_description": "New Funding For Blood Testing Company",
    "raised_amount": 100000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2007,
    "funded_month": 5,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Merseyside Special Investment Fund",
         "permalink": "merseyside-special-investment-fund",
         "image":
          {"available_sizes":
            [[[150,
               65],
              "assets/images/resized/0025/2098/252098v1-max-150x150.jpg"],
             [[250,
               109],
              "assets/images/resized/0025/2098/252098v1-max-250x250.jpg"],
             [[254,
               111],
              "assets/images/resized/0025/2098/252098v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Human Anatomy \u0026 Cell Biology",
    "address2": "The Sherrington Building, Ashton Street",
    "zip_code": "L69 3GE",
    "city": "Liverpool",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        114],
       "assets/images/resized/0008/1223/81223v1-max-150x150.jpg"],
      [[250,
        190],
       "assets/images/resized/0008/1223/81223v1-max-250x250.jpg"],
      [[450,
        343],
       "assets/images/resized/0008/1223/81223v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}